Department of Psychiatry (UPK), University of Basel, Basel, 4002, Switzerland.
Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, 4031, Switzerland.
Neuropsychopharmacology. 2021 Feb;46(3):545-553. doi: 10.1038/s41386-020-00906-2. Epub 2020 Nov 20.
It has been reported that serotonergic hallucinogens like lysergic acid diethylamide (LSD) induce decreases in functional connectivity within various resting-state networks. These alterations were seen as reflecting specific neuronal effects of hallucinogens and it was speculated that these shifts in connectivity underlie the characteristic subjective drug effects. In this study, we test the hypothesis that these alterations are not specific for hallucinogens but that they can be induced by monoaminergic stimulation using the non-hallucinogenic serotonin-norepinephrine-dopamine releasing agent 3,4-methylenedioxymethamphetamine (MDMA). In a randomized, placebo-controlled, double-blind, crossover design, 45 healthy participants underwent functional magnetic resonance imaging (fMRI) following oral administration of 125 mg MDMA. The networks under question were identified using independent component analysis (ICA) and were tested with regard to within-network connectivity. Results revealed decreased connectivity within two visual networks, the default mode network (DMN), and the sensorimotor network. These findings were almost identical to the results previously reported for hallucinogenic drugs. Therefore, our results suggest that monoaminergic substances can induce widespread changes in within-network connectivity in the absence of marked subjective drug effects. This contradicts the notion that these alterations can be regarded as specific for serotonergic hallucinogens. However, changes within the DMN might explain antidepressants effects of some of these substances.
据报道,血清素能致幻剂,如麦角酸二乙酰胺(LSD),会导致各种静息状态网络内的功能连接减少。这些改变被认为反映了致幻剂对特定神经元的影响,有人推测这些连接的变化是致幻药物特征性主观效应的基础。在这项研究中,我们通过使用非致幻性血清素-去甲肾上腺素-多巴胺释放剂 3,4-亚甲二氧基甲基苯丙胺(MDMA)来测试以下假设,即这些改变并非特定于致幻剂,而是可以由单胺能刺激引起。在一项随机、安慰剂对照、双盲、交叉设计中,45 名健康参与者在口服 125mg MDMA 后接受了功能磁共振成像(fMRI)检查。使用独立成分分析(ICA)确定了所研究的网络,并对网络内的连接进行了测试。结果显示,两个视觉网络、默认模式网络(DMN)和感觉运动网络内的连接减少。这些发现与先前报道的致幻药物的结果几乎相同。因此,我们的结果表明,单胺能物质可以在没有明显的药物主观效应的情况下,引起网络内连接的广泛变化。这与这些改变可以被视为特定于血清素能致幻剂的观点相矛盾。然而,DMN 内的变化可能可以解释这些物质中的一些抗抑郁药物的作用。